Clinical Trials

Showing trials with last updates posted in 2019.

NCT02423083 | TERMINATED | PHASE1
2 participants

Oral Guanabenz for Multiple Sclerosis

Study Type:
INTERVENTIONAL
Last Updated:
2019-12-12
Start Date:
2015-04-21
Completion:
2017-10-30
Conditions
  • Multiple Sclerosis, Relapsing-Remitting
  • Multiple Sclerosis
Interventions
  • DRUG
No Results Yet
NCT02186574 | UNKNOWN | PHASE3
184 participants

Tenofovir to Prevent HBV Reactivation

Study Type:
INTERVENTIONAL
Last Updated:
2019-12-12
Start Date:
2015-05-31
Completion:
2021-02-28
Conditions
  • Hepatitis B
  • Lymphoma
  • Non-Hodgkin
Interventions
  • DRUG
No Results Yet
NCT01316809 | COMPLETED | PHASE1
22 participants

AZD8055 for Adults With Recurrent Gliomas

Study Type:
INTERVENTIONAL
Last Updated:
2019-12-12
Start Date:
2011-03-04
Completion:
2014-04-14
Conditions
  • Glioblastoma Multiforme
  • Anaplastic Astrocytoma
  • Anaplastic Oligodendroglioma
  • Malignant Glioma
  • Brainstem Glioma
Interventions
  • DRUG
No Results Yet
NCT00924092 | COMPLETED | PHASE1
25 participants

An Open Label Phase I Study to Eval the Safety and Tolerability of a Vaccine (GI-6207) Consisting of Whole, Heat-killed Recombinant Saccharomyces Cerevisiae (Yeast) Genetically Modified to Express CEA Protein in Adults With Metastatic CEA-expressing ...

Study Type:
INTERVENTIONAL
Last Updated:
2019-12-12
Start Date:
2009-03-13
Conditions
  • Prostate Cancer
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Head and Neck Cancer
Interventions
  • BIOLOGICAL
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page